Add to ORKGKRN5500, a spicamycin derivative, exerts anti-myeloma effects through impairing both myeloma cells and osteoclast
Multiple myeloma is a plasma cell malignancy and develops in the bone marrow. The myeloma bone disea...
Cellular effects and metabolic stability of N 1-cyclic inosine diphosphoribose and its derivative
Zinn, KR et al.. Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tum...
KRN5500, a spicamycin derivative, exerts anti-myeloma effects through impairing both myeloma cells...
All tyrosine kinase inhibitor-resistant chronic myelogenous cells are highly sensitive t
Melphalan-induced DNA damage in vitro as predictor for clinical outcome in multiple myeloma
Multiple myeloma is a plasma cell malignancy and develops in the bone marrow. The myeloma bone disea...
Cellular effects and metabolic stability of N 1-cyclic inosine diphosphoribose and its derivative
Zinn, KR et al.. Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tum...
KRN5500, a spicamycin derivative, exerts anti-myeloma effects through impairing both myeloma cells...
All tyrosine kinase inhibitor-resistant chronic myelogenous cells are highly sensitive t
Melphalan-induced DNA damage in vitro as predictor for clinical outcome in multiple myeloma
Multiple myeloma is a plasma cell malignancy and develops in the bone marrow. The myeloma bone disea...
Cellular effects and metabolic stability of N 1-cyclic inosine diphosphoribose and its derivative
Zinn, KR et al.. Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tum...